The Differencies in Adult and Pediatric Myelodysplastic Syndrome: A Review

1. THEPOT S., BOEHRER S., SEKERES V. et al. (2014). A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure. Leuk Res 38: 1430-143410.1016/j.leukres.2014.09.014Search in Google Scholar

2. RANKIN E. B., NARLA A., PARK J. K. et al. (2015). Biology of the bone marrow microenvironment and myelodysplastic syndromes. Mol Genet Metab 116: 24-2810.1016/j.ymgme.2015.07.004Search in Google Scholar

3. A DES L., ITZYKSON R., FENAUX P. (2014). Myelodysplastic syndrome. Lancet 383:2239-225210.1016/S0140-6736(13)61901-7Search in Google Scholar

4. CAZZOLA M., DELLA PORTA M. G, TRAVAGLINO E. et al. (2011). Classification and Prognostic Evaluation of Myelodysplastic Syndromes. Semin Oncol 38 (5): 627-63410.1053/j.seminoncol.2011.04.00721943669Search in Google Scholar

5. SWERDLOW S. H., CAMPO E., HARRIS N.L. et al. (2008). World Health Organization Classification of Tumours of Hematopoetic and Lymphoid Tissues. 4th Edition. Lyon: IARC Press 2008: 86-103.Search in Google Scholar

6. NIEMEYER CH. M., KRATZ CH. P. (2008). Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol 140: 610-62410.1111/j.1365-2141.2007.06958.x18302710Search in Google Scholar

7. HASLE H., NIEMEYER CH. M. (2011). Advances in the prognostication and management of advanced MDS in children. Br J Haematol 154: 185–19510.1111/j.1365-2141.2011.08724.x21554264Search in Google Scholar

8. ORAZI A., CZADER B. M. (2009). Myelodysplastic Syndromes. Am J Clin Pathol 132: 290-30510.1309/AJCPRCXX4R0YHKWV19605823Search in Google Scholar

9. INAGAKI J., FUKANO R., KARAUCHI K. et al. (2015). Hemopoetic stem cell transplantation in children with refractory cytopenia of childhood: Single-center experience with high dose cytarabine containing myeloablative and aplastic anemia oriented reduced – intensity conditioning regimens. Biol Blood Marrow Transplant 21 (3): 565-56910.1016/j.bbmt.2014.12.00325498905Search in Google Scholar

10. HASEGAWA D., CHEN X., HIRABAYASHI S. et al. (2014). Clinical characteristics and treatement outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification. Br J Haematol 166: 758-76610.1111/bjh.1295524894311Search in Google Scholar

11. NIEMEYER CH. M., BAUMANN I. (2011). Classification of childhood aplastic anemia and myelodysplastic syndromes. ASH Educational Book 2011 (1): 84-8910.1182/asheducation-2011.1.8422160017Search in Google Scholar

12. CHATTERJEE T., CHOUDHRY V. P. (2013). Childhood Myelodysplastic Syndrome. Indian J Pediatr 80 (9): 764-77110.1007/s12098-013-1130-823912822Search in Google Scholar

13. BASQUIRA A. L., PIZZI S., CORREAS A. G. et al. (2015). Allogenic hematopoetic stem cell transplantation in pediatric MDS: A multicenter experience from Argentina. Pediatr. Blood Cancer 62: 153-157Search in Google Scholar

14. HASLE H., NIEMEYER CH. M., CHESSELS J. M. et al. (2003). A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative disease. Leukemia 17: 277-28210.1038/sj.leu.240276512592323Search in Google Scholar

15. GLAUBACH T., ROBINSON L. J., COREY S. J. (2014). Pediatric Myelodysplastic Syndromes: They Do Exist! J Pediatr Hematol Oncol 36 (1): 1-710.1097/MPH.000000000000004624345881Search in Google Scholar

16. WU J. CHENG Y., ZHANG L. (2015). Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study. Leuk Res 39 (12): 1347-1352Search in Google Scholar

17. JÄDERSTEN M., HELLSTRÖM-LINDBERG E. (2008). Myelodysplastic syndromes: biology and treatement. J Intern Med 265: 307-32810.1111/j.1365-2796.2008.02052.x19141095Search in Google Scholar

18. GREENBERG P. L. (2012). Molecular and genetic features of myelodysplastic syndrome. Int. Jnl. Lab. Hem. 34 : 215-222.Search in Google Scholar

19. WEINZIERL E. P., ARBER D. A. (2013). The differential diagnosis and bone marrow evaluation of new-onset pancytopenia. AM J Clin Pathol. 139: 9-2910.1309/AJCP50AEEYGREWUZ23270895Search in Google Scholar

20. VISCONTE V., LINDSLEY R. C., BERLYNE D. et al. (2015). Aplastic Anemia & MDS International Foundation (AA & MDS IF): Bone Marrow Failure Disease Scientific Symposium 2014. Leuk Res 39: 110-11310.1016/j.leukres.2014.11.00825435026Search in Google Scholar

21. GORDON-SMITH E. C. (2011). Blood and Bone Marrow Pathology (Second Edition). CHURCHILL LIVINGSTONE ELSEVIER, 2011, p. 213-224, ISBN 978-0-7020-3147-2Search in Google Scholar

22. KAO J. M., GREENBERG P. L. (2007). Myelodysplastic Syndromes: Impact of Recently Analyzed Variables for Modifying Current Classification Methods. Clinical Leukemia 1 (3) : 172-18210.3816/CLK.2007.n.005Search in Google Scholar

23. RADICH J. (2008). Solving the Mystery of Myelodysplasia. PLoS Med 5(2): e4010.1371/journal.pmed.0050040223589518271622Search in Google Scholar

24. INVERNIZZI R., FILOCCO A. (2010). Myelodysplastic syndrome: classification and prognostic systems. Oncol Rev 4: 25–3310.1007/s12156-009-0033-4Search in Google Scholar

25. MITTELMAN M., OSTER. H. S., HOFFMAN M. at al. (2010). The lower risk MDS patient at risk of rapid progression. Leuk Res 34: 1551-155510.1016/j.leukres.2010.05.02320573398Search in Google Scholar

26. AMERI A. A., CHERRY M., GARCIA-MANNERO G. et al. (2011). Standard Therapy for Patients With Myelodysplastic Syndromes. Clin Lymphoma Myeloma Leuk 11 (4): 303-31310.1016/j.clml.2011.06.00821816368Search in Google Scholar

27. SEKERES M. A (2013). The euphoria of hypomethylating agents in MDS and AML: Is it justified? Best Pract Res Clin Haematol. 26: 275-278Search in Google Scholar

28. PILO F., DI TUCCI A. A., DESSALVI P. et al. (2010). The evolving clinical scenario of myelodysplastic syndrome: The need for a complete and up to date upfront diagnostic assesment. Eur J Intern Med 21: 490–49510.1016/j.ejim.2010.09.00321111932Search in Google Scholar

29. MALCOVATI L., HELLSTRÖM-LINDBERG E., BOWEN D. et al. (2013). Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 122 (17) : 2943-296410.1182/blood-2013-03-492884381117023980065Search in Google Scholar

30. VALENT P., ORAZIS A., BÜSCHE G. et al. (2010). Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS). Oncotarget 1: 483 – 49610.18632/oncotarget.185Search in Google Scholar

31. HORNY H.-P., SOTLAR K., VALENT. P. (2007). Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes. Leuk Res 31: 1609–161610.1016/j.leukres.2007.05.01017604834Search in Google Scholar

32. HASSERIJAN R. P. (2015). Advances in the diagnosis and classification of myelodysplastic syndromes. Diagn Histopathol 21 (5): 203-21110.1016/j.mpdhp.2015.06.005Search in Google Scholar

33. MEERS S. (2014). The myelodysplastic syndromes: the area of understanding. Eur J Haematol 94: 379-39010.1111/ejh.1244325186093Search in Google Scholar

34. GIAGOUNIDIS A., HAASE D. (2013). Morphology, cytogenetics and classification of MDS. Best Pract Res Clin Haematol 26 : 337-35310.1016/j.beha.2013.09.00424507811Search in Google Scholar

35. BAUMANN I., FÜHRER M., BEHRENDT S. et al. (2012). Morphological differentiation of severe aplastic anemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology 61: 10-1710.1111/j.1365-2559.2011.04156.x22458667Search in Google Scholar

36. HAMA A., MANABE A., HASEGAWA D. et al. (2015). Comparison of clinical features between aplastic anemia and refractory cytopenia of childhood. Haematologica 100 (s2) : p2Search in Google Scholar

37. BAUMANN I. (2015). Morphologic diagnosis of RCC vs. SAA. Oral presentation-Keynote Lecture. 7th International Symposium on Myelodysplastic Syndromes, JMML and Bone Marrow Failure, Aarhus, Denmark, 1-3 October 2015Search in Google Scholar

38. FOUCAR K., VISWANATHA D.S., WILSON C. S. (2008). Non neoplastistic disorders of bone marrow, First series, Fascicle 6. Washington DC: ARP Press 2008: 84-89Search in Google Scholar

39. PARKER-WILLIAMS E. (2009). Investigation and management of anaemia. Medicine 37 (3): 137-14210.1016/j.mpmed.2009.01.005Search in Google Scholar

40. BIZZARO N., ANTICO A. (2014). Diagnosis and classification of pernicious anemia. Autoimmun Rev 13: 565-56810.1016/j.autrev.2014.01.04224424200Search in Google Scholar

41. BARONE A., LUCARELLI A., ONOFRILLO D. et al. (2015). Diagnosis and management of Acquired Aplastic Anemia in Childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Heamato-Oncology Italian Association (AIEOP). Blood Cells Mol Dis 55 (1): 40-47Search in Google Scholar

42. GARCIA-MANERO G. (2015). Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification, and management. Am. J. Hematol. 90 (9): 832-84010.1002/ajh.2410226294090Search in Google Scholar

43. SMITH A. R., CHRISTIANSEN E. C., WAGNER J. E. et al. (2013). Early Hematopoetic Stem Cell Transplant Is Associated With Favorable Outcomes In Children With MDS. Pediatr. Blood Cancer 60: 705-710Search in Google Scholar